Eastman Chemicals Chinese Joint Venture Begins Production of Esters and Plasticizers

Eastman Chemical Company announced today that Qilu Eastman Specialty Chemical Ltd. has begun operations in Zibo, Shandong Province, People’s Republic of China. QESCL is a joint venture between Sinopec Qilu Petrochemical Company and Eastman Chemical Ltd., a wholly owned subsidiary of Eastman Chemical Company.

The new plant produces Texanol ester alcohol and TXIB plasticizer. The plant is able to meet the total demand of Eastman’s current customers for these products in China. Construction of the plant began in September 2003.

"The joint venture enhances Eastman's global capacity for Texanol ester alcohol and TXIB plasticizer. We expect a healthy growth in our market segment for these products and have an optimistic outlook for the future of the plant," said Damon Warmack, Asia Pacific region president for the company’s Eastman Division.

Eastman expects the synergy established with Sinopec Qilu will provide long-term business growth opportunities in China, and the Asia Pacific region in general, with a stable and efficient supply of raw material from its joint venture partner.

“The plant is identical, both in design and operation process, with our plant in Singapore and is tied into Eastman’s global operation,” said Brian Yoon, general manager, QESCL. “That means our customers will get the same consistent, high-quality products that they have come to expect from Eastman.”

Texanol ester alcohol is the leading coalescing aid used in premium quality architectural paints around the world. It is produced within Eastman’s coatings, adhesives, special polymers and inks segment. TXIB plasticizer is a primary plasticizer for vinyl, urethanes and other polymers for the production of consumer goods such as flooring, wallpaper, artificial leather and disposable medical examination gloves. It is produced within the company’s performance chemicals and intermediates segment.

For more information on plasticizers, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.